Bioclate Articles
GTC's ATryn granted orphan status by FDA
17 December 2007
Europabio welcomes Lithuania prosecution
17 December 2007
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flagging pipeline
17 December 2007
GTC and ProGenetics sign licensing deal
10 December 2007
Abraxis licenses Abraxane to Green Cross for Korea
3 December 2007
DOR BioPharma in CRADA for ricin toxin vaccine research
26 November 2007
Stock Commentary - New York week to Nov 19
26 November 2007
Primlintide/leptin combo produces 12.7% weight loss, says Amylin
26 November 2007
Benda to enter India's $204M oncology market
26 November 2007
Biovitrum sees flat nine-month revenue
12 November 2007
Novo Nordisk's nine-month profit soars 60%
12 November 2007
EU funded scientists decode proteins with medicines potential
5 November 2007
Akorn and India's Serum Inst sign US vacc deal
5 November 2007
Baxter's 3rd-qtr 2007 net income rises 6%
29 October 2007
Headlines 25 years ago this week....
22 October 2007
Baxter adds recombinant protein to portfolio
22 October 2007
Avesthagen-Cipla buys Siegfreid unit
15 October 2007
ThromboGenics signs THR-174 R&D accord
15 October 2007
Japan stock market week to October 1, 2007
8 October 2007
Chugai withdraws Epogin application
8 October 2007
Prix Galien for Merck & Co's Gardasil and Januvia
27 September 2007
A-Bio signs production deal for Artisan's DIC drug
24 September 2007
Immutep's IMP321 activates wide range of immune cells
24 September 2007
Japan's NIID extends accord with HemiSpherx
17 September 2007
FDA fast-track for GTC's ATryn
10 September 2007
ThromboGenics transfers technology to Bharat
10 September 2007
Rhucin meets Ph III HAE study endpoint
10 September 2007
UPDATE: Sandoz' biosimilar epoetin cleared in EU
10 September 2007
Biovitrum's 2nd-qtr 2007 income soars 33%
10 September 2007
EMEA OKs BeneFix modifications
3 September 2007
Millipore to distribute Novo's insulin for cell culture
3 September 2007
Headlines 25 years ago this week....
20 August 2007
Ipsen/Tercica's Increlex approved in Europe
20 August 2007
Biovitrum enters Nordic BeneFIX co-promo deal
13 August 2007
AM-Pharma secures 2.5M euro financing deal
13 August 2007
Chinese firm Simcere 2nd-qtr revenues and income leap
13 August 2007
Pharming loss deepens 8.7% in 1st-half 2007
6 August 2007
TG halts tgAAC94 trial after death of patient
6 August 2007
Biotica wins patent case against Kosan
30 July 2007
ATryn introduced at ISTH conference
26 July 2007
Rotateq/Gardasil on all US VFC programs
23 July 2007
Pegylation of Factor VIII improves function
23 July 2007
Tercica and Genentech sign R&D deal
16 July 2007
New 2,000 IU vial size for Bayer's Kogenate
9 July 2007
EC approves Merck KGaA's Pergoveris
9 July 2007
ZymoGenetics licenses rThrombin to Bayer
25 June 2007
Co-development deal for Dong-A, Genexine
25 June 2007
VaxGen ends anthrax vaccine development
4 June 2007
Neose gets milestone on Factor IX program
4 June 2007
Ark's Trinam gets US go ahead for Phase III
28 May 2007
Tercica in manufacturing deal with Lonza
21 May 2007
Sanofi Pasteur MSD's Gardasil shows strong efficacy in FUTURE trials but questions remain
21 May 2007
Ark requests approval for US Trinam trial
7 May 2007
Merck & Co's 1st-qtr income climbs 12%
30 April 2007
FDA approves Protalix' Ph III prGCD trial
23 April 2007
NHI price cuts hit Bayer Yakuhin results
23 April 2007
Merrimack starts Ph II MM-093 enrollment
23 April 2007
Strong data for Dyax' HAE drug
23 April 2007
Organon
16 April 2007
Laureate opens new preclinical protein facility
16 April 2007
FDA approves ammendments to Wyeth's BeneFIX
2 April 2007
MilleGen and LFB SA enter MAb R&D accord
26 March 2007
Polish biotech Bioton buys Biopartners
26 March 2007
UK heath panel delays Gardasil
19 March 2007
GTC and PharmAthene extend licensing accord
19 March 2007
Sym001 enters Ph I ITP and HDN trial
19 March 2007
TopoTarget in-licenses Zemab from Novartis
19 March 2007
Novo Nordisk growing in Japan
19 March 2007
Fusion Antibodies signs deal with Arius
12 March 2007
Stock Commentary - Europe - week to March 5, 2007
12 March 2007
Stock Commentary - New York week to Feb 26, 2007
5 March 2007
Placebo groups to be switched to Gardasil
5 March 2007
NovoSeven misses Ph III trial primary endpoint
5 March 2007
Biovitrum's FY 2006 net profit plummets 47.4%
5 March 2007
Merck & Co suspends lobbying to make Gardasil compulsory ahead of report on its side effects
26 February 2007
Hylenex may have role in analgesia, says trial
26 February 2007
Ambrx initiates Ph I/II ARX201 trial
19 February 2007
World vaccine market to exceed $15 billion in 2012
19 February 2007
CT creates new firm to develop Genetic Polymer technology
19 February 2007
Bayer's Kogenate gets EU OK for use in surgery
19 February 2007
Wyeth enters three major collaborations
12 February 2007
Fresenius in new deal with Amgen
12 February 2007
CSL and Bayer extend Helixate deal
12 February 2007
Novo's full-year 2006 net profit rises 10%
12 February 2007
Merck & Co's 4th-qtr income plunges 58%
5 February 2007
Baxter's 4th-qtr net earnings up 47%
5 February 2007
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
